Sam Waksal plans IPO for new biotech company
September 24, 2014 at 07:31 AM EDT
Sam Waksal's new biotech company, Kadmon, has plans to go public. The company aims to file a form S-1 with the SEC by the end of this year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.